Antiseptic Patient Preoperative Skin Preparation And Surgical Hand Scrub Solution
NDC Package 67326-352-08
Package Information
Antiseptic Patient Preoperative Skin Preparation And Surgical Hand Scrub (povidone-iodine) solution is patient preoperative skin preparation:Clean the areaApply product to the operative site prior to surgeryScrub thoroughly for 5 minutesRinse off with a sterile gauze saturated with waterSurgical hand scrub:Clean under nails with a nail pick. This formulation utilizes a solution delivery system. Marketed by Degasa Sa De Cv, this product is identified by NDC 67326-352 and is authorized under FDA application 505G(a)(3).
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 67326 - Degasa Sa De Cv
- 67326-352 - Antiseptic Patient Preoperative Skin Preparation And Surgical Hand Scrub
- 67326-352-08 - 48 BOTTLE in 1 CASE / 118 mL in 1 BOTTLE
- 67326-352 - Antiseptic Patient Preoperative Skin Preparation And Surgical Hand Scrub
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (67326-352). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 67326-352-08 identifies a specific commercial package of 48 bottle in 1 case / 118 ml in 1 bottle of Antiseptic Patient Preoperative Skin Preparation And Surgical Hand Scrub, a human over the counter drug labeled by Degasa Sa De Cv. This solution is formulated for topical use and contains povidone-iodine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Degasa Sa De Cv on August 13, 2015. The current certification is valid through December 31, 2026.
How is this Degasa Sa De Cv product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 67326035208. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.